Page last updated: 2024-08-03 20:02:24

bellergal

Description

Cross-References

ID Source	ID
PubMed CID	56841786
MeSH ID	M0129794

Synonyms (5)

Synonym
bellergal-s
belladonna alkaloid, ergotamine, phenobarbital drug combination
bellergal
57657-51-9
DTXSID30206356

Research

Studies (15)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	6 (40.00)	18.7374
1990's	3 (20.00)	18.2507
2000's	5 (33.33)	29.6817
2010's	1 (6.67)	24.3611
2020's	0 (0.00)	2.80

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	1 (6.25%)	5.53%
Reviews	7 (43.75%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	8 (50.00%)	84.16%

Substance	Studies	Classes	Roles	First Year	Last Year	Average Age	Relationship Strength	Trials	pre-1990	1990's	2000's
gamma-aminobutyric acid	2	amino acid zwitterion; gamma-amino acid; monocarboxylic acid	human metabolite; neurotransmitter; Saccharomyces cerevisiae metabolite; signalling molecule	2003	2005	20.0	low	0	0	0	2
amitriptyline	1	carbotricyclic compound; tertiary amine	adrenergic uptake inhibitor; antidepressant; environmental contaminant; tropomyosin-related kinase B receptor agonist; xenobiotic	1984	1984	40.0	low	0	1	0	0
clonidine	3	clonidine; imidazoline		1990	2005	25.3	low	0	0	1	2
cyproheptadine	1	piperidines; tertiary amine	anti-allergic agent; antipruritic drug; gastrointestinal drug; H1-receptor antagonist; serotonergic antagonist	1984	1984	40.0	low	0	1	0	0
gabapentin	2	gamma-amino acid	anticonvulsant; calcium channel blocker; environmental contaminant; xenobiotic	2003	2005	20.0	low	0	0	0	2
phenobarbital	15	barbiturates	anticonvulsant; drug allergen; excitatory amino acid antagonist; sedative	1949	2010	37.7	high	1	6	3	6
propranolol	1	naphthalenes; propanolamine; secondary amine	anti-arrhythmia drug; antihypertensive agent; anxiolytic drug; beta-adrenergic antagonist; environmental contaminant; human blood serum metabolite; vasodilator agent; xenobiotic	1984	1984	40.0	low	0	1	0	0
sulpiride	1	benzamides; N-alkylpyrrolidine; sulfonamide	antidepressant; antiemetic; antipsychotic agent; dopaminergic antagonist	2003	2003	21.0	low	0	0	0	1
medroxyprogesterone acetate	1	20-oxo steroid; 3-oxo-Delta(4) steroid; acetate ester; corticosteroid; steroid ester	adjuvant; androgen; antineoplastic agent; antioxidant; female contraceptive drug; inhibitor; progestin; synthetic oral contraceptive	2003	2003	21.0	low	0	0	0	1
cyclohexanol	1	cyclohexanols; secondary alcohol	solvent	2010	2010	14.0	low	0	0	0	1
ergotamine	1	peptide ergot alkaloid	alpha-adrenergic agonist; mycotoxin; non-narcotic analgesic; oxytocic; serotonergic agonist; vasoconstrictor agent	1984	1984	40.0	low	0	1	0	0
methysergide	10	ergoline alkaloid		1984	2005	27.1	medium	1	2	3	5
lithium carbonate	1	carbonate salt; lithium salt	antimanic drug	1984	1984	40.0	low	0	1	0	0
megestrol acetate	1	20-oxo steroid; 3-oxo-Delta(4) steroid; acetate ester; steroid ester	antineoplastic agent; appetite enhancer; contraceptive drug; progestin; synthetic oral contraceptive	2003	2003	21.0	low	0	0	0	1
d-alpha tocopherol	2	alpha-tocopherol	algal metabolite; antiatherogenic agent; anticoagulant; antioxidant; antiviral agent; EC 2.7.11.13 (protein kinase C) inhibitor; immunomodulator; micronutrient; nutraceutical; plant metabolite	2003	2005	20.0	low	0	0	0	2
phenyl acetate	1	benzenes; phenyl acetates		2003	2003	21.0	low	0	0	0	1
methyldopa	1	L-tyrosine derivative; non-proteinogenic L-alpha-amino acid	alpha-adrenergic agonist; antihypertensive agent; hapten; peripheral nervous system drug; sympatholytic agent	2005	2005	19.0	low	0	0	0	1
agreal	1	sulfonamide		2003	2003	21.0	low	0	0	0	1
venlafaxine hydrochloride	1	hydrochloride		2010	2010	14.0	low	0	0	0	1
naproxen	1	methoxynaphthalene; monocarboxylic acid	antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; environmental contaminant; gout suppressant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic	1984	1984	40.0	low	0	1	0	0
diethylstilbestrol	1	olefinic compound; polyphenol	antifungal agent; antineoplastic agent; autophagy inducer; calcium channel blocker; carcinogenic agent; EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; endocrine disruptor; xenoestrogen	2003	2003	21.0	low	0	0	0	1
lithium	1	alkali metal atom		1984	1984	40.0	low	0	1	0	0
fosfestrol	1	aryl phosphate		2003	2003	21.0	low	0	0	0	1
phytoestrogens	1			2003	2003	21.0	low	0	0	0	1

Condition	Studies	First Year	Last Year	Average Age	Relationship Strength	pre-1990	1990's	2000's
Abdominal Migraine	1	1984	1984	40.0	low	1	0	0
Acrodynia	1	1949	1949	75.0	low	1	0	0
Anxiety	1	1953	1953	71.0	low	1	0	0
Atypical Cluster Headache	1	1984	1984	40.0	low	1	0	0
Benign Neoplasms	1	2005	2005	19.0	low	0	0	1
Breast Cancer	1	2001	2001	23.0	low	0	0	1
Breast Neoplasms	1	2001	2001	23.0	low	0	0	1
Cancer of Prostate	1	2003	2003	21.0	low	0	0	1
Cephalgia, Vascular	1	1984	1984	40.0	low	1	0	0
Chronic Insomnia	1	1997	1997	27.0	low	0	1	0
Complications, Pregnancy	1	1984	1984	40.0	low	1	0	0
Depression, Postpartum	1	2010	2010	14.0	low	0	0	1
Dermatoses	1	1957	1957	67.0	low	1	0	0
Flushing	1	1990	1990	34.0	low	0	1	0
Hot Flashes	5	2001	2005	20.6	medium	0	0	5
Menopause	3	1997	2005	22.3	medium	0	1	2
Migraine Disorders	1	1984	1984	40.0	low	1	0	0
Neoplasms	1	2005	2005	19.0	low	0	0	1
Post-Natal Depression	1	2010	2010	14.0	low	0	0	1
Pregnancy	2	1984	2010	27.0	low	1	0	1
Prostatic Neoplasms	1	2003	2003	21.0	low	0	0	1
Skin Diseases	1	1957	1957	67.0	low	1	0	0
Sleep Initiation and Maintenance Disorders	1	1997	1997	27.0	low	0	1	0

bellergal

Description

Cross-References

Synonyms (5)

Research

Studies (15)

Study Types

Related Drugs (24)

Drugs Researched Together (24)

Related Conditions (23)